52W Range | $0.001-$0.05 |
Shares Short | 60,340 |
Revenue (12 Mos) | $419.2M |
Revenue Growth (YoY) | 17.1% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.41 |
CEO | Mr. Jeffrey M. Jagid |
CFO | Mr. Christopher Broderick |
Address | 270 Sylvan Avenue, Englewood Cliffs, NJ, United States, 07632 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 0 |